Oxford University spinout Vaccitech will use investment from GV, Oxford Sciences Innovation and Sequoia China to advance a universal flu vaccine and address other diseases requiring cellular immune activation.
We publish news of technology innovations, investment opportunities, together with updates from spin-out & start-up companies and licensees
Gene therapy spinout Nightstar Therapeutics signs deal with Oxford University Innovation to tackle Stargardt disease.
Alex McCallion, Oxford University graduate and research assistant at the Saïd Business School, is launching a crowdfunding campaign to develop a mobile phone app that will help people leave homelessness behind for good.
Oxford University Innovation’s digital health deal with Drayson Technologies and Oxford University Hospitals celebrated at annual OBN awards.